Therapy-type related long-term outcomes in mucopolysaccaridosis type II (Hunter syndrome) - Case series.
Mol Genet Metab Rep
; 28: 100779, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-34258227
CNS, central nervous system; ENT, ear nose and throat specialist; ERT, enzyme replacement therapy; GAG, glycosaminoglycans; HSCT, enzyme replacement therapy; HSCT, hematopoietic stem cell transplantation; Hematopoietic stem cell transplantation; Hunter syndrome; I2S, iduronate-2-sulfatase; LSD, lysosomal storage disease; MPS; MPS, mucopolysaccharidosis; Mucopolysaccharidosis type II
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Mol Genet Metab Rep
Año:
2021
Tipo del documento:
Article
País de afiliación:
Eslovenia
Pais de publicación:
Estados Unidos